18 results
DEF 14A
NMRA
Neumora Therapeutics Inc.
25 Apr 24
Definitive proxy
4:05pm
assessment and oversight are an integral part of our governance and management processes. Our Board encourages management to promote a culture … assessment and management;
reviewing our accounting and financial reporting policies and practices and accounting controls, as well as compliance with legal
10-K
2023 FY
NMRA
Neumora Therapeutics Inc.
7 Mar 24
Annual report
4:05pm
score that received at least one dose of study drug and had at least one post-baseline HAMD-17 assessment), and baseline demographics were balanced … applications relating to biomarkers. Generally speaking, those selected biomarkers include genetic, proteomic, task-based, clinical assessment-based
10-Q
2023 Q3
NMRA
Neumora Therapeutics Inc.
1 Nov 23
Quarterly report
4:05pm
securities in an unrealized loss position, this assessment first considers the Company’s intent to sell, or whether it is more likely than … the aforementioned criteria, the Company assesses whether the decline in fair value has resulted from credit losses or other factors. In making this assessment
424B4
NMRA
Neumora Therapeutics Inc.
18 Sep 23
Prospectus supplement with pricing info
4:12pm
from the requirement to obtain an attestation and report from our independent registered public accounting firm on the assessment of our internal … to reach a definitive agreement for a collaboration will depend, among other things, upon our assessment of the collaborator’s resources and expertise
S-1/A
g31 bnii8wa
11 Sep 23
IPO registration (amended)
6:07am
S-1
EX-2.1
hu2mmdtbfdlmmala
25 Aug 23
IPO registration
5:03pm
S-1
phu2da 2perapmv
25 Aug 23
IPO registration
5:03pm
S-1
EX-10.2
x90k4kt7
25 Aug 23
IPO registration
5:03pm
S-1
EX-2.2
rz3xeam
25 Aug 23
IPO registration
5:03pm
DRS/A
0qj7xdwg
9 Aug 23
Draft registration statement (amended)
12:00am
DRS/A
ght8vrzzitav
30 Jun 23
Draft registration statement (amended)
12:00am
DRS/A
brhlc xgt7r
2 May 23
Draft registration statement (amended)
12:00am
DRS/A
0movywuup96v8 clvo
2 Sep 22
Draft registration statement (amended)
12:00am
DRS/A
rdaj3hvqc5v
10 Jun 22
Draft registration statement (amended)
12:00am
DRS/A
nade94bv8tphsjyk
2 May 22
Draft registration statement (amended)
12:00am
DRS/A
bbbjbxj8m fkbx
23 Dec 21
Draft registration statement (amended)
12:00am
DRS
e2lac7k1mq ga46h
8 Nov 21
Draft registration statement
12:00am
- Prev
- 1
- Next